Pudugramam Murali Doraiswamy
#132,978
Most Influential Person Now
Pudugramam Murali Doraiswamy's AcademicInfluence.com Rankings
Pudugramam Murali Doraiswamyphilosophy Degrees
Philosophy
#6563
World Rank
#9619
Historical Rank
Logic
#3712
World Rank
#4910
Historical Rank
Download Badge
Psychology Philosophy
Pudugramam Murali Doraiswamy's Degrees
- Doctorate Medicine Stanford University
- PhD Psychology Stanford University
Why Is Pudugramam Murali Doraiswamy Influential?
(Suggest an Edit or Addition)Pudugramam Murali Doraiswamy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of exercise training on older patients with major depression. (1999) (1199)
- Use of florbetapir-PET for imaging beta-amyloid pathology. (2011) (938)
- Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder (2007) (830)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (2012) (652)
- Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. (2002) (448)
- Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. (2003) (404)
- Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics (2011) (372)
- Cognitive Function in Late Life Depression: Relationships to Depression Severity, Cerebrovascular Risk Factors and Processing Speed (2006) (358)
- Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature (2003) (340)
- Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. (1992) (339)
- Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. (2011) (322)
- Olanzapine‐Associated Diabetes Mellitus (2002) (293)
- Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome (2018) (288)
- Analysis of European mitochondrial haplogroups with Alzheimer disease risk (2004) (283)
- Metabolic network failures in Alzheimer's disease: A biochemical road map (2017) (280)
- Yoga on Our Minds: A Systematic Review of Yoga for Neuropsychiatric Disorders (2012) (279)
- Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study (2018) (272)
- Default mode network connectivity in stable vs progressive mild cognitive impairment (2011) (271)
- Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. (2010) (271)
- Hypercortisolemia and hippocampal changes in depression (1993) (269)
- Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. (2003) (267)
- A magnetic resonance imaging study of putamen nuclei in major depression (1991) (259)
- Metabolomic mapping of atypical antipsychotic effects in schizophrenia (2007) (249)
- Prevalence and impact of medical comorbidity in Alzheimer's disease. (2002) (243)
- Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. (2013) (236)
- Marked gender differences in progression of mild cognitive impairment over 8 years (2015) (234)
- Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis. (2016) (215)
- Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. (2012) (213)
- Pituitary size in depression. (1991) (211)
- Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects (1991) (201)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Current Status of Metals as Therapeutic Targets in Alzheimer's Disease (2003) (200)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline (2012) (198)
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging (2013) (197)
- Risperidone‐Associated Diabetes Mellitus: A Pharmacovigilance Study (2003) (175)
- Use of Florbetapir-PET for Imaging-Amyloid Pathology (2011) (172)
- Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study (2014) (171)
- Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study (2014) (171)
- Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease (2013) (165)
- Alterations in metabolic pathways and networks in Alzheimer's disease (2013) (164)
- Metals in our minds: therapeutic implications for neurodegenerative disorders (2004) (157)
- A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. (2000) (157)
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers (2018) (151)
- Cardiac complications and delirium associated with valerian root withdrawal. (1998) (144)
- Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. (2007) (139)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- Atypical Antipsychotics and Pituitary Tumors: A Pharmacovigilance Study (2006) (135)
- Non-cholinergic strategies for treating and preventing Alzheimer's disease. (2002) (134)
- Delivering happiness: translating positive psychology intervention research for treating major and minor depressive disorders. (2011) (132)
- In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. (1990) (131)
- Metabolomic changes in autopsy-confirmed Alzheimer's disease (2011) (129)
- In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: Relationship to dexamethasone suppression test results in patients (1992) (129)
- Neuroanatomical substrates of depression in the elderly (2005) (126)
- The Alzheimer's disease assessment scale (1997) (124)
- Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals (2013) (124)
- A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia (2019) (124)
- Does antidepressant therapy improve cognition in elderly depressed patients? (2003) (122)
- A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. (2004) (117)
- Severe hyperglycemia associated with high doses of clozapine. (1994) (115)
- Mild cognitive impairment: evaluation with 4-T functional MR imaging. (2006) (112)
- Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline (2013) (111)
- Proton spectroscopy of human brain: Effects of age and sex (1994) (110)
- Occurrence of subcortical hyperintensities in elderly subjects with mania (1991) (109)
- Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem (2004) (109)
- Long-term effects of rivastigmine in moderately severe Alzheimer's disease Does early initiation of therapy offer sustained benefits? (2002) (107)
- Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers (2019) (106)
- Current Status of Antioxidant Therapy for Alzheimer's Disease (1998) (106)
- The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease (2001) (104)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Cholinergic therapy for Down's syndrome (1999) (103)
- Coenzyme Q10: A Review of Its Promise as a Neuroprotectant (2007) (100)
- Does Meditation Enhance Cognition and Brain Plasticity? (2009) (97)
- Exercise fails to improve neurocognition in depressed middle-aged and older adults. (2008) (97)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Frontal White Matter Anisotropy and Antidepressant Remission in Late-Life Depression (2008) (96)
- Brain imaging in clinical psychiatry (1997) (94)
- Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study (1992) (93)
- PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies (2015) (91)
- Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. (2014) (90)
- Brain magnetic resonance imaging findings in ECT-induced delirium. (1990) (89)
- Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment (2007) (89)
- Pharmacological strategies for the prevention of Alzheimer’s disease (2006) (89)
- Pancreatitis Associated with Atypical Antipsychotics: From the Food and Drug Administration's MedWatch Surveillance System and Published Reports (2003) (88)
- The spectrum of quality-of-life impairments in recurrent geriatric depression. (2002) (86)
- The largest human cognitive performance dataset reveals insights into the effects of lifestyle factors and aging (2013) (86)
- In vivo stereological assessment of caudate volume in man: effect of normal aging. (1990) (85)
- In vivo stereological assessment of human cerebellar volume: effects of gender and age. (1991) (85)
- Hippocampal abnormalities in depression. (1991) (84)
- MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. (1992) (83)
- A Systematic Review of Antidepressant Placebo-Controlled Trials for Geriatric Depression: Limitations of Current Data and Directions for the Future (2004) (82)
- Magnetic resonance imaging in social phobia (1994) (79)
- Prediction of cognitive decline in early Alzheimer's disease (1998) (78)
- Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure. (2002) (76)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease (2018) (74)
- Accelerating stem cell trials for Alzheimer's disease (2016) (72)
- Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome (2020) (71)
- Subcortical brain anatomy in anorexia and bulimia (1992) (71)
- Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease (2013) (69)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Treatment course with antidepressant therapy in late-life depression. (2012) (69)
- Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. (2007) (68)
- Mobile and pervasive computing technologies and the future of Alzheimer’s clinical trials (2018) (66)
- Comparative mortality risks of antipsychotic medications in community-dwelling older adults. (2014) (66)
- Artificial Intelligence and the Future of Psychiatry: Insights from a Global Physician Survey (2019) (66)
- Lifestyle and neurocognition in older adults with cognitive impairments (2019) (66)
- Elevation in Plasma Abeta42 in Geriatric Depression: A Pilot Study (2006) (66)
- Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. (1993) (65)
- Health perception, pain, and disability as correlates of anxiety and depression symptoms in primary care patients. (2002) (64)
- Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis. (2009) (63)
- Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders. (2001) (63)
- The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden. (2014) (63)
- A randomized controlled trial of paroxetine for noncardiac chest pain. (2006) (62)
- Reboxetine: A Selective Norepinephrine Reuptake Inhibitor for the Treatment of Depression (2000) (60)
- Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease (2017) (60)
- Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack☆ (2013) (60)
- Aging of the human corpus callosum: magnetic resonance imaging in normal volunteers. (1991) (59)
- Cognitive Deficits Following Coronary Artery Bypass Grafting: Prevalence, Prognosis, and Therapeutic Strategies (2004) (59)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Cerebrovascular Risk Factors, Vascular Disease, and Neuropsychological Outcomes in Adults With Major Depression (2007) (55)
- A review of 1H MR spectroscopy findings in Alzheimer's disease. (2005) (55)
- Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. (2008) (54)
- Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease (2020) (54)
- Screening for Early Alzheimer's Disease: Is There Still a Role for the Mini-Mental State Examination? (2005) (53)
- Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. (2012) (53)
- Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. (2003) (53)
- Levels of urinary free cortisol in social phobia. (1991) (53)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24‐week open trial (2003) (51)
- Mifepristone (RU 486) for Alzheimer's disease. (2002) (50)
- A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings (2015) (50)
- In vivo amyloid imaging in Alzheimer’s disease (2004) (50)
- ECT-induced delirium in depressed patients with Parkinson's disease. (1991) (49)
- Magnetic resonance spectroscopy in Alzheimer's disease: focus on N‐acetylaspartate (2000) (49)
- A magnetic resonance image study of age-related changes in human putamen nuclei. (1991) (48)
- Reduction of cerebellar volume in major depression: A controlled MRI study (1993) (48)
- Donepezil effects on language in children with Down syndrome: Results of the first 22‐week pilot clinical trial (2004) (47)
- Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve (2007) (47)
- Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging (2013) (46)
- Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. (1992) (46)
- Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? (1998) (46)
- Marked Increase in Alzheimer's Disease Identified in Medicare Claims Records Between 1991 and 1999 (2004) (46)
- Magnetic resonance findings in patients with early-onset Alzheimer's disease (1991) (45)
- Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. (2006) (45)
- Social cognition in major depressive disorder: A new paradigm? (2013) (44)
- A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia (1990) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE (2015) (44)
- Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth (2013) (44)
- Cognitive performance on the Alzheimer's Disease Assessment Scale (1995) (44)
- Detecting neurodegenerative disorders from web search signals (2018) (42)
- Olanzapine‐Associated Severe Hyperglycemia, Ketonuria, and Acidosis: Case Report and Review of Literature (2001) (42)
- Atypical antipsychotic drugs and hyperglycemia in adolescents. (2001) (42)
- Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study. (2006) (42)
- Clinical and treatment response characteristics of late-life associated with vascular disease: A pooled analysis of two multicenter trials with sertraline (2001) (41)
- Effects of Donepezil on Cortical Activation in Mild Cognitive Impairment: A Pilot Double-Blind Placebo-Controlled Trial Using Functional MR Imaging (2008) (41)
- Review of the use of mirtazapine in the treatment of depression (2011) (40)
- Assessment of posterior fossa structures with midsagittal MRI: The effects of age (1991) (40)
- Hippocampal sulcal cavities on MRI: Relationship to age and apolipoprotein E genotype (2000) (39)
- Intima-media thickness and age of first depressive episode (2009) (39)
- Defining Meaningful Change in Alzheimer's Disease Trials: The Donepezil Experience (1999) (38)
- A New Spin on Neural Processing: Quantum Cognition (2016) (36)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) supported by Emerging Digital Technologies (2019) (35)
- Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS‐C16 and QIDS‐SR16) in the elderly (2010) (35)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- From weight loss to weight gain: appetite changes in major depressive disorder as a mirror into brain-environment interactions (2013) (34)
- Accuracy of spatial normalization of the hippocampus: Implications for fMRI research in memory disorders (2006) (34)
- Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. (2014) (34)
- Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI) (2016) (33)
- Alzheimer's disease and the glutamate NMDA receptor. (2003) (33)
- Hippocampal volume and the Mini-Mental State Examination in the diagnosis of amnestic mild cognitive impairment. (2007) (32)
- When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer’s Disease (2014) (32)
- Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting (2019) (32)
- Health-related quality-of-life and service utilization in Alzheimer's disease: A cross-sectional study (2000) (31)
- Bicaudate Index on Magnetic Resonance Imaging: Effects of Normal Aging (1994) (30)
- Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012 (2013) (30)
- Educational attainment and hippocampal atrophy in the Alzheimer's disease neuroimaging initiative cohort. (2014) (30)
- Wernicke-Korsakoff syndrome caused by psychogenic food refusal: MR findings. (1994) (29)
- Pituitary abnormalities in eating disorders: Further evidence from MRI studies (1991) (29)
- Imaging genetics of brain longevity and mental wellness: the next frontier? (2008) (29)
- Hippocampal atrophy confounds template-based functional MR imaging measures of hippocampal activation in patients with mild cognitive impairment. (2006) (28)
- Citalopram and quality of life in lung transplant recipients. (2004) (28)
- Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. (2001) (28)
- Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? (2005) (28)
- Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression. (2014) (27)
- NSAIDs and cognition in Alzheimer's disease (1996) (27)
- Brain Magnetic Resonance Spectroscopy (2000) (27)
- Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action (2016) (27)
- Donepezil for Down's syndrome. (2001) (26)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease (2019) (26)
- Serum triglycerides in Alzheimer disease (2020) (26)
- Effectiveness of Florbetapir PET Imaging in Changing Patient Management (2017) (26)
- Effects of aerobic exercise on sexual functioning in depressed adults (2009) (26)
- Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial. (2018) (25)
- Empowering 8 Billion Minds: Enabling Better Mental Health for All via the Ethical Adoption of Technologies. (2019) (25)
- Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial. (2007) (25)
- Lack of association between UBQLN1 and Alzheimer disease (2006) (25)
- Cholinesterase Inhibitors and Pisa Syndrome: A Pharmacovigilance Study (2014) (25)
- Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
- Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients (2017) (25)
- Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings. (1999) (24)
- Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment (2017) (24)
- Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. (2018) (23)
- Eat Now or Later: Self-Control as an Overlapping Cognitive Mechanism of Depression and Obesity (2015) (23)
- Interuncal distance as a measure of hippocampal atrophy: normative data on axial MR imaging. (1993) (23)
- Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research. (2005) (23)
- Caudate Hyperintensities in Elderly Depressed Patients With Neuroleptic-Induced Parkinsonism (1991) (22)
- Statins and Cognition: What Can We Learn from Existing Randomized Trials? (2005) (22)
- Contemporary management of comorbid anxiety and depression in geriatric patients. (2001) (22)
- Differential food intake and food choice by depression and body mass index levels following a mood manipulation in a buffet-style setting (2019) (22)
- Learning and recall in subjects at genetic risk for Alzheimer's disease. (2002) (22)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer's disease: A pilot observational study (2004) (21)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- Impact of 18F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making (2014) (20)
- Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. (2013) (20)
- Anticholinergic drugs and elderly people: a no brainer? (2006) (20)
- Combination Therapy for Early Alzheimer's Disease: What Are We Waiting for? (1998) (20)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- Bupropion SR in the naturalistic treatment of elderly patients with major depression (2001) (19)
- Science to Practice: Translating Automated Brain MRI Volumetry in Alzheimer’s Disease from Research to Routine Diagnostic Use in the Work-Up of Dementia (2014) (19)
- Interuncal distance measurements in healthy volunteers and in patients with Alzheimer disease. (1993) (19)
- Ocular amyloid imaging at the crossroad of Alzheimer’s disease and age-related macular degeneration: implications for diagnosis and therapy (2018) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease (2021) (19)
- Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition? (2016) (18)
- Functional MRI in the early diagnosis of Alzheimer’s disease: is it time to refocus? (2008) (17)
- Mood disorders and chronic obstructive pulmonary disease: Current research and future needs (2002) (17)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Modulation of a human memory circuit by subsyndromal depression in late life: a functional magnetic resonance imaging study. (2009) (16)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- Computerized Cognitive Training for Major Depressive Disorder: What’s Next? (2015) (16)
- Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives (2013) (16)
- Prefrontal activation patterns in subjects at risk for Alzheimer disease. (2002) (15)
- Preimplantation genetic diagnosis for inherited neurological disorders (2014) (15)
- Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. (2007) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design. (2014) (15)
- The role of the N-methyl-D-aspartate receptor in Alzheimer’s disease: Therapeutic potential (2003) (15)
- Serum triglycerides in Alzheimer’s disease: Relation to neuroimaging and CSF biomarkers (2018) (15)
- Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations. (1997) (15)
- Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression (1991) (14)
- Emergency department patterns in psychiatric visits during the holiday season. (1994) (14)
- Effect of Bupropion SR on the Quality of Life of Elderly Depressed Patients With Comorbid Medical Disorders. (1999) (14)
- The Biology of Alzheimer Disease (2012) (14)
- Alzheimer's Disease: 100 Years of Progress (2005) (14)
- Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset (2021) (13)
- Longer Term Effects of Diet and Exercise on Neurocognition: 1‐Year Follow‐up of the ENLIGHTEN Trial (2019) (13)
- Preimplantation genetic diagnosis (PGD) for genetic prion disorder due to F198S mutation in the PRNP gene. (2014) (13)
- The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease (2003) (13)
- Efficacy and safety of St. John's wort for the treatment of major depression (2000) (12)
- Neurobiology of chronic fatigue syndrome (1996) (12)
- What is the role of pharmacogenetics in clinical psychiatry? (2013) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World (2020) (12)
- Increasing memory load modulates regional brain activity in older adults as measured by fMRI. (2005) (11)
- Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose. (2001) (11)
- Change in Sense of Nondual Awareness and Spiritual Awakening in Response to a Multidimensional Well-Being Program. (2018) (11)
- Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia. (2001) (11)
- Development of a drug safety ePlatform for physicians, pharmacists, and consumers based on post-marketing adverse events (2013) (11)
- Magnetic resonance evaluation of the midbrain in Parkinson's disease. (1991) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization (2021) (10)
- MR imaging of physiologic pituitary gland hypertrophy in adolescence. (1991) (10)
- Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression. (2010) (10)
- Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians. (2015) (10)
- Magnetic resonance imaging in biological psychiatry (1991) (10)
- Phase III trial results for the amyoid PET imaging agent Florbetapir F 18 (18F-AV-45): imaging to histopathologic correlations in an end-of-life human subject study (2010) (10)
- Brain atrophy rates in first degree relatives at risk for Alzheimer's (2014) (10)
- The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE‐II randomized clinical trial (2020) (10)
- Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor. (1991) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Computerized Cognitive Training by Healthy Older and Younger Adults: Age Comparisons of Overall Efficacy and Selective Effects on Cognition (2021) (9)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- Parsing the genetic heterogeneity of chromosome 12q susceptibility genes for Alzheimer disease by family-based association analysis (2006) (9)
- Interventions for mild cognitive impairment and Alzheimer disease: new strategies, new hope. (2003) (9)
- The Alzheimer Structural Connectome: Changes in Cortical Network Topology with Increased Amyloid Plaque Burden. (2016) (9)
- Treating cognitive deficits in multiple sclerosis (2004) (9)
- Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression (2021) (9)
- Alzheimer's Disease: An Overview of Recent Developments and a Look to the Future. (2017) (9)
- Atypical antipsychotics and pituitary neoplasms in the WHO database. (2007) (9)
- Exercise to combat depression. (2014) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Importance of Social Determinants in Screening for Depression (2021) (8)
- 2 – Current Concepts in Hypothalamo—Pituitary—Adrenal Axis Regulation (1991) (8)
- Increased Pituitary Volume in …Psychosis Study (2006) (8)
- Simultaneous major depression and panic disorder: treatment with electroconvulsive therapy. (1992) (8)
- Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease (2021) (7)
- Magnetic resonance imaging hyperintensities in Alzheimer's disease. (1991) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- Cortical β-amyloid levels and neurocognitive performance after cardiac surgery (2013) (7)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- Diagnosis of Alzheimer's Disease through the Eye and its Correlation with Cognitive Tests and Brain Imaging (2014) (7)
- Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men (2010) (7)
- Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition (2019) (7)
- Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention? (2012) (6)
- Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD) (2022) (6)
- Integrating Positive Psychiatry Into Clinical Practice (2015) (6)
- A Pilot to Investigate the Feasibility of Mobile Cognitive Assessment of elderly patients and caregivers in the home (2016) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias (2009) (6)
- Probing gut‐brain links in Alzheimer's disease with rifaximin (2021) (6)
- Association Between Insulin Resistance, Serum Leptin, and Neurocognition in Vascular Cognitive Impairment. (2019) (6)
- Molecular PET imaging in multicenter Alzheimer’s therapeutic trials: current trends and implementation strategies (2011) (6)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer's Disease (2011) (5)
- cognitive decline : A multicenter study assessed by florbetapir F 18 PET and 18-month β Amyloid- (2012) (5)
- Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study (2022) (5)
- The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors (2012) (5)
- Comorbidity of age-related macular degeneration with Alzheimer’s disease: A histopathologic case-control study (2019) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- Ginkgo and memory. (2003) (5)
- Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease. (1996) (5)
- Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review (2020) (5)
- The Self-Directed Biological Transformation Initiative and Well-Being. (2016) (5)
- Ask the Experts: What is the utility of amyloid imaging from the point of view of the clinician? (2011) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- FOCUS ON CITALOPRAM : A SELECTIVE SEROTONIN REUPTAKE INHIBITOR FOR THE TREATMENT OF DEPRESSION (1998) (4)
- Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder (2018) (4)
- Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study (2009) (4)
- The Alzheimer’s Disease Metabolome: Effects of Sex and APOE ε4 genotype (2019) (4)
- Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps (2017) (4)
- From the bridges of Königsberg to the fields of Alzheimer (2013) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Is the Idle Mind a Devil's Workshop? (2012) (4)
- Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment. (2021) (4)
- Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. (2021) (3)
- Vascular dementia: the end stage of cerebral vascular disease (1998) (3)
- Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment. (2016) (3)
- COMMENTARY The Spiritual Heart: Can Gratitude Change Cardiac Biology? (2015) (3)
- Relapse of depression after electroconvulsive therapy. (2001) (3)
- Alterations in metabolic pathways and networks in mild cognitive impairment and early Alzheimer's disease (2013) (3)
- ALTERED BILE ACID METABOLITES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE: RELATION TO NEUROIMAGING AND CSF BIOMARKERS (2018) (3)
- Corrigendum: Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI) (2016) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- Causality-Guided Feature Selection (2016) (3)
- Florbetapir F 18 (18F-AV-45) PET amyloid imaging predicts progression of cognitive impairment: A longitudinal clinical follow up study (2010) (3)
- Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer’s Disease: A 78-week Randomized Controlled Trial (2022) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- No calorie comfort: Viewing and drawing “comfort foods” similarly augment positive mood for those with depression (2018) (2)
- Current and future treatments for cognitive deficits in dementia (2000) (2)
- How Much Is a Picture Worth? Putting Amyloid Imaging to the Test (2012) (2)
- Magnetic resonance imaging (MRI)--morphometric study. (1991) (2)
- Serum Metabolites Associated with Brain Amyloid Beta Deposition, Cognitive Dysfunction, and Alzheimer’s Disease Progression (2020) (2)
- Targeted lipidomic pathway-guided genetic association with Alzheimer's disease–relevant endophenotypes (2013) (2)
- Computerized Games versus Crosswords Training in Mild Cognitive Impairment (2022) (2)
- Prognostic significance of florbetapir F18 PET imaging in MCI and mormal elderly: Final results from a longitudinal multicenter trial (2011) (2)
- Exercise and Pharmacological Treatment of Depressive Symptoms in Patients with Coronary Heart Disease: Results from the UPBEAT Study (2012) (2)
- Changes in pituitary gland signal intensity and morphology as evaluated by magnetic resonance imaging in aging, depression, and by gender (1994) (2)
- Characterizing Gene and Protein Crosstalks in Subjects at Risk of Developing Alzheimer’s Disease: A New Computational Approach (2017) (2)
- O1-02-08 Statin use and hippocampal volume in subjects at risk for Alzheimer's disease (2004) (2)
- Left anterior parahippocampal gray matter volume is inversely associated with APOE genotypic risk in healthy seniors: Tensor-based morphometry data (2009) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- Structural Changes in the Aging Brain (2002) (1)
- Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging (2013) (1)
- A preliminary randomized, double-blind, placebo controlled study of the effects of citalopram (Celexa) on depression, anxiety and quality of life in patients with severe COPD. (COPD: 12:00pm-1:45pm) (2002) (1)
- EVALUATION OF EVENT RELATED POTENTIALS AND QUANTITATIVE EEG AS USEFUL BIOMARKERS FOR THE DIAGNOSIS OF EARLY-STAGE ALZHEIMER'S DISEASE (2014) (1)
- General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity (2021) (1)
- P4-041 Rates of diagnosis of vascular dementia over 10 years in the United States medicare claims records (2004) (1)
- Relationship of Florbetapir F18 PET Amyloid Plaque Neuroimaging with Future Cognitive Decline over 36 Months (2013) (1)
- MRI QUANTIFICATION. REPLY (1991) (1)
- Expanding the scope of health disparities research in Alzheimer's disease and related dementias (2023) (1)
- Baseline Plasma GABA: Its Relationship to the Adverse Effects of Acute Lorazepam Administration on Cognition in the Elderly (2004) (1)
- Advancing computerized cognitive training for early Alzheimer's disease in a pandemic and post-pandemic world (2020) (1)
- Analysis of relationships between cortical structural connections, global and local amyloid burden, and cognitive performace in Alzheimer's dementia (2013) (1)
- Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study (1)
- fMRI encoding task correlation with voxel-based morphometry of the hippocampus in healthy controls, mild cognitive impairment, and Alzheimer's disease (2009) (1)
- THE IMPORTANCE OF EARLY DIAGNOSIS TO DESIRABLE PATIENT OUTCOMES (1999) (1)
- Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment. (2022) (1)
- Knowledge-Guided Maximal Clique Enumeration (2016) (0)
- IC-P3-204: Effects of donepezil on cortical activation in MCI: A placebo controlled fMRI study (2008) (0)
- EXERCISE TRAINING AND MAJOR DEPRESSION (1999) (0)
- IC-P2-125: Functional and structural MRI measures of cognitive progression in Alzheimer's disease (2008) (0)
- MAGNETIC RESONANCE EVALUATION OF THE MIDBRAIN IN PARKINSON'S DISEASE. AUTHOR'S REPLY (1991) (0)
- APOE ε4 effects on florbetapir F18 PET in Alzheimer's disease, mild cognitive impairment and normal aging (2011) (0)
- The differences in CD33 protein expression for AA and EA suggest that race and gender play a role in CD33 expression, the gene product of the CD33 susceptibility locus. P3-055 PREECLAMPSIA DURING PREGNANCYAND ALZHEIMER’S DISEASE LATER IN LIFE (2013) (0)
- MRI quantification [7] (1991) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- ASSOCIATION OF SERUM-BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER’S DISEASE (2019) (0)
- Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization (2021) (0)
- Predictors of response to sertraline in elderly major depression (1999) (0)
- A multicenter clinical trial to validate Event-Related Potentials (ERPs) as useful biomarkers for early detection of Alzheimer's (2012) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- A Comprehensive Approach to Mental Health Promotion and Suicide Prevention for Colleges and Universities: Insights from the JED Campus Program. (2021) (0)
- Analysis of relationships between cortical structural connections, global and local amyloid burden and cognitive performance in Alzheimer's dementia (2013) (0)
- Digital Cognitive Training in MCI and Early AD: Real World Evidence and Insights from a Large Online Cohort (2022) (0)
- Prognostic significance of Florbetapir (18F-Florbetapir) PET imaging for future cognitive performance in recently diagnosed MCI: Final results from a 3-year multicenter longitudinal trial (2012) (0)
- PET scanning in mild cognitive impairment. (2007) (0)
- APOE E4 effects on florbetapir F18 PET in Alzheimer's disease, mild cognitive impairment and normal aging (2011) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- Evidence-based treatment of psychiatric disorders with comorbid medical illnesses: the need for large simple clinical trials. (2007) (0)
- Robust postmortem correlates of florbetapir-PET beta-amyloid imaging of Alzheimer's disease subjects despite neuropathologic heterogeneity (2012) (0)
- Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease (2017) (0)
- A multicenter clinical trial to validate event-related potentials as useful biomarkers for early detection of Alzheimer's disease (2013) (0)
- Targeted lipidomic-pathway–guided genetic association with Alzheimer's disease–relevant endophenotypes (2013) (0)
- Predicting cognitive decline in MCI subjects using the Fusion ICA Toolbox to combine multimodality neuroimaging data (2011) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- may yield important insights into genetic influences on the biology of Alzheimer’s disease (AD).We investigated the accuracy of a novel unsuper- vised multimodal biomarker classifier for differentiating cognitively normal elderly (NC) from subjects with amnestic mild cognitive impairment (2019) (0)
- RESPONSE TO LETTERS TO THE EDITOR (2008) (0)
- Left anterior parahippocampal gray matter volume is inversely associated with APOE genotypic risk in healthy seniors: tensor-based morphometry data (2009) (0)
- MAGNETIC RESONANCE IMAGING HYPERINTENSITIES IN ALZHEIMER'S DISEASE. AUTHOR'S REPLIES (1991) (0)
- Magnetic resonance imaging in idiopathic hypopituitarism (1991) (0)
- Reproductive Markers in Alzheimer’s Disease Progression: The Framingham Heart Study (2023) (0)
- THE ALZHEIMER’S METABOLOME: RELATIONSHIP TO PATHOLOGICAL MARKERS AND COGNITIVE DECLINE IN THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI) (2016) (0)
- St. John’s Wort: What Is it? Can it Help Depression? (1997) (0)
- Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series. (2021) (0)
- P2-189 Comparison of FMRI activation patterns in mild cognitive impairment (MCI) subjects and elderly controls at ultra-high field strength (2004) (0)
- PROTON MR SPECTROSCOPY OF THE FRONTAL CORTEX IN COGNITIVELY NORMAL SUBJECTS: EFFECT OF AGE (1999) (0)
- Therapeutic Strategies in Depression with Cognitive Impairment (2018) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- FEASIBILITYAND OUTCOMES OF A NATIONAL MEMORY SCREENING DAYAT A COMMUNITY (2015) (0)
- Marked gender differences in rate of cognitive decline in subjects at risk for Alzheimer’s disease (2015) (0)
- Dessert Food: Delay discounting as a function of BMI and depression level for a dessert food. (2015) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- EARLY RECOGNITION AND TREATMENT OF ALZHEIMERʼS DISEASE: WHATʼS NEW? WHATʼS CONTROVERSIAL? WHATʼS PRACTICAL? (1999) (0)
- Cortical Deactivation in Mild Cognitive Impairment: High-Field-StrengthFunctionalMR (2007) (0)
- P2-249 Marked increase in Alzheimer's disease identified in medicare claims records between 1991 and 1999 (2004) (0)
- Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study (2022) (0)
- Models of depressive pseudoamnestic disorder (2022) (0)
- Pre-exposure cognitive performance variability is associated with severity of respiratory infection (2022) (0)
- COGNITIVE CHANGE AND ANTIDEPRESSANT TREATMENT IN DEP-MCI: DO RACE AND GENDER MATTER? (2018) (0)
- Featured Article Marked gender differences in progression of mild cognitive impairment over 8 years (2015) (0)
- Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease (2018) (0)
- SERUM TRIGLYCERIDES IN ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING, CSF, AND GENETIC VARIATION (2019) (0)
- Predicting cognitive decline in MCI subjects using the fusion ICA toolbox to combine multimodality neuroimaging data (2011) (0)
- Dementia Clinical Research in India (2014) (0)
- BUPROPION SR IN THE NATURALISTIC TREATMENT OF MAJOR DEPRESSION IN ELDERLY PATIENTS WITH HIGH AND LOW MEDICAL COMORBIDITY (1999) (0)
- IMPACT OF CALORIE RESTRICTION ON PLASMA ALZHEIMER’S DISEASE BIOMARKERS IN HEALTHY YOUNG AND MIDDLE-AGED ADULTS (2022) (0)
- GowthamAtluri a ,KanchanaPadmanabhan b , GangFang c ,MichaelSteinbach a ,JeffreyR.Petrella d ,KelvinLim e , (2013) (0)
- Novel 18F radioligand for PET imaging of Alzheimer's disease (2008) (0)
- MRI detection of abnormality in the corpus callosum and late-onset depression (1993) (0)
- Advancing computerized cognitive training for early Alzheimer's disease in a Covid-19 pandemic and post-pandemic world (2020) (0)
- PreimplantationGeneticDiagnosis(PGD)forGeneticPrion DisorderDuetoF198SMutationinthePRNPGene (2014) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- WHOLE GENE-BASED ASSOCIATION OF BASELINE PLASMA HOMOCYSTEINE IN THE ADNI-1 COHORT (2014) (0)
- P4-080 Genetic studies of Alzheimer disease on chromosome 9P (2004) (0)
- Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies (2013) (0)
- The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores (2021) (0)
- P2-005: PET imaging of amyloid-beta in Alzheimer's disease with 18F-av-144 (2008) (0)
- Data-driven causal model discovery and personalized prediction in Alzheimer's disease (2022) (0)
- Serum metabolome informs neuroimaging biomarkers for Alzheimer’s disease (2020) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- The Alzheimer’s metabolome: Identification of novel markers and treatment targets (2015) (0)
- Alzheimer’s Disease: The Importance of Early Diagnosis and Appropriate Management [CME] (2013) (0)
- Left hippocampal volume adds significant diagnostic accuracy to MMSE in the identification of MCI (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pudugramam Murali Doraiswamy?
Pudugramam Murali Doraiswamy is affiliated with the following schools:
